Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MLSS Stock Forecast 2026-2027
$0.28
Current Price
$22.69M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MLSS Price Targets
+254.6%
To High Target of $1.00
+254.6%
To Median Target of $1.00
+254.6%
To Low Target of $1.00
MLSS Price Momentum
0.0%
1 Week Change
-3.4%
1 Month Change
-68.9%
1 Year Change
+3.7%
Year-to-Date Change
-74.6%
From 52W High of $1.11
+28.2%
From 52W Low of $0.22
📊 TOP ANALYST CALLS
Did MLSS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Milestone Scientific is one of their latest high-conviction picks.
Latest MLSS Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, MLSS has a bullish consensus with a median price target of $1.00 (ranging from $1.00 to $1.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $0.28, the median forecast implies a 254.6% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MLSS Analyst Ratings
2
Buy
0
Hold
0
Sell
MLSS Price Target Range
Low
$1.00
Average
$1.00
High
$1.00
Current: $0.28
Latest MLSS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MLSS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 20, 2025 | Benchmark | Speculative Buy | Maintains | $N/A | |
| Nov 20, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Reiterates | $1.25 |
| Oct 10, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Initiates | $1.25 |
Milestone Scientific Inc. (MLSS) Competitors
The following stocks are similar to Milestone Scientific based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Milestone Scientific Inc. (MLSS) Financial Data
Valuation Metrics
Market Cap
$22.69M
Enterprise Value
$22.60M
P/E Ratio
N/A
PEG Ratio
-7.1x
Price/Sales
2.5x
Growth & Margins
Revenue Growth (YoY)
+2.2%
Gross Margin
+73.0%
Operating Margin
-52.5%
Net Margin
-63.8%
EPS Growth
+2.2%
Financial Health
Cash/Price Ratio
+5.0%
Current Ratio
1.8x
Debt/Equity
36.3x
ROE
-132.4%
ROA
-40.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Milestone Scientific Inc. (MLSS) Business Model
About Milestone Scientific Inc.
What They Do
Develops advanced medical devices for precise drug delivery.
Business Model
Milestone Scientific generates revenue by developing, producing, and commercializing medical devices that utilize its patented pressure feedback technology for controlled drug delivery. The primary focus is on enhancing pain management in dentistry through its STA System, with plans for expansion into broader medical applications.
Additional Information
The company is positioned to transform traditional medical practices with its innovative solutions, contributing to a global trend towards minimally invasive procedures and improved patient care. Its technology not only targets dental procedures but also aims to enhance safety and comfort in various medical injections.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15
CEO
Mr. Neal Ira Goldman CFA
Country
United States
IPO Year
1995
Website
www.milestonescientific.comMilestone Scientific Inc. (MLSS) Latest News & Analysis
Latest News
Quick Summary
Milestone Scientific Inc. (MLSS) held its Q4 2025 earnings call, discussing financial performance and future plans. Further details can be obtained from the full transcript.
Why It Matters
The Q4 2025 earnings call for Milestone Scientific Inc. provides insights into financial performance, growth potential, and future strategies, which are crucial for assessing investment opportunities.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Milestone Scientific Inc. (NYSE: MLSS) anticipates a transition to growth in Q4 2025, with projected double-digit revenue growth and a 400% increase in CompuFlo sales for 2026.
Why It Matters
Milestone Scientific's transition to growth and projected double-digit revenue increases signal potential for significant stock appreciation and improved profitability, attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Milestone Scientific Inc. (NYSE: MLSS) will host a conference call on April 1, 2026, at 8:30 AM ET to discuss Q4 and full-year 2025 financial results and corporate developments.
Why It Matters
Milestone Scientific's upcoming conference call will reveal critical financial results and updates, influencing investor sentiment and stock performance based on growth and operational insights.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Milestone Scientific Inc. (NYSE: MLSS) launched the CompuFlo® Advisor Program, enhancing its offerings in computerized drug delivery instruments.
Why It Matters
The launch of the CompuFlo® Advisor Program may enhance Milestone Scientific's market position and revenue potential, signaling growth opportunities that could positively impact stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A pilot program has started with six dental professionals, aiming to expand to 250 ambassadors within a year.
Why It Matters
The scaling of this dental program indicates potential growth and increased market presence, which could enhance revenue and investor confidence in the company’s future prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Milestone Scientific Inc. (MLSS) will hold its Q3 2025 earnings call on November 14, 2025, at 8:30 AM EST, featuring CEO Eric Hines and VP of Finance Keisha Harcum.
Why It Matters
Milestone Scientific's Q3 earnings call provides insights into financial performance and strategic updates, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About MLSS Stock
What is Milestone Scientific Inc.'s (MLSS) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Milestone Scientific Inc. (MLSS) has a median price target of $1.00. The highest price target is $1.00 and the lowest is $1.00.
Is MLSS stock a good investment in 2026?
According to current analyst ratings, MLSS has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.28. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MLSS stock?
Wall Street analysts predict MLSS stock could reach $1.00 in the next 12 months. This represents a 254.6% increase from the current price of $0.28. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Milestone Scientific Inc.'s business model?
Milestone Scientific generates revenue by developing, producing, and commercializing medical devices that utilize its patented pressure feedback technology for controlled drug delivery. The primary focus is on enhancing pain management in dentistry through its STA System, with plans for expansion into broader medical applications.
What is the highest forecasted price for MLSS Milestone Scientific Inc.?
The highest price target for MLSS is $1.00 from at , which represents a 254.6% increase from the current price of $0.28.
What is the lowest forecasted price for MLSS Milestone Scientific Inc.?
The lowest price target for MLSS is $1.00 from at , which represents a 254.6% increase from the current price of $0.28.
What is the overall MLSS consensus from analysts for Milestone Scientific Inc.?
The overall analyst consensus for MLSS is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $1.00.
How accurate are MLSS stock price projections?
Stock price projections, including those for Milestone Scientific Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 19, 2026 6:21 PM UTC